City Therapeutics Sets Advance Notice Rules for Stockholder Proposals

• City Therapeutics’ amended bylaws took effect October 15, 2026, establishing procedures for stockholder actions at meetings.
• The bylaws require advance notice of stockholder proposals, including board nominations, for annual meetings.
• A revised certificate of incorporation filed October 19, 2026, eliminates stockholders’ ability to act by written consent or call special meetings.
• The certificate authorizes 500,000,000 common shares and 10,000,000 undesignated preferred shares issuable by the board in one or more series.
• These certificate changes were approved to take effect immediately before completion of the initial public offering.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. City Therapeutics Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-116947), on October 19, 2026, and is solely responsible for the information contained therein.